Cannabinoids May Treat Prostate Cancer That’s Nonresponsive to Common Therapies

Cannabinoids may cannabinoidsprovide a treatment option for prostate cancer that has become nonresponsive to common therapy, according to a study published in the February issue of the journal Oncology Reports, and published online this week by the National Institute of Health.

According to researchers; “In the early stages, prostate cancer is androgen‑ dependent; therefore, medical castration has shown significant results during the initial stages of this pathology. Despite this early effect, advanced prostate cancer is resilient to such treatment.”

Read moreCannabinoids May Treat Prostate Cancer That’s Nonresponsive to Common Therapies